CHMP recommend market authorisation change for Fortacin (lidocaine / prilocaine cutaneous spray)

The CHMP have recommended that this spray, licensed for the treatment of primary premature ejaculation in adult men, can be available as a medicinal product not subject to medical prescription.

Source:

European Medicines Agency